Compared to Estimates, Clarivate (CLVT) Q4 Earnings: A Look at Key Metrics

Core Insights - Clarivate PLC reported a revenue of $663 million for the quarter ended December 2024, reflecting a 3% decline year-over-year, with EPS at $0.21 compared to $0.23 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $658.05 million by 0.75%, while the EPS also surpassed the consensus estimate of $0.20 by 5% [1] Revenue Breakdown - Intellectual Property revenues were $209.10 million, falling short of the average estimate of $212.56 million, representing a year-over-year decline of 7.3% [4] - Life Sciences & Healthcare revenues totaled $111 million, below the average estimate of $114.48 million, marking a 6.5% decrease year-over-year [4] - Academia & Government revenues reached $342.90 million, exceeding the estimated $333.63 million, showing a 1% increase compared to the previous year [4] - Transactional and other revenues were reported at $144 million, surpassing the average estimate of $130.13 million, but reflecting a 6.4% decline year-over-year [4] - Re-occurring revenues amounted to $112 million, below the average estimate of $121.63 million, indicating a 6% decrease year-over-year [4] - Subscription revenues were $407 million, compared to the average estimate of $425.73 million, representing a slight decline of 0.9% year-over-year [4] Stock Performance - Clarivate's shares have returned -9.9% over the past month, contrasting with the Zacks S&P 500 composite's +4.7% change [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]